D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$362M |
| 2 |
Lockheed Martin
LMT
|
+$361M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$354M |
| 4 |
Fidelity National Information Services
FIS
|
+$354M |
| 5 |
Boston Scientific
BSX
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$559M |
| 2 |
Advanced Micro Devices
AMD
|
+$558M |
| 3 |
Boeing
BA
|
+$530M |
| 4 |
Lowe's Companies
LOW
|
+$525M |
| 5 |
Alibaba
BABA
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Consumer Discretionary | 10.41% |
| 3 | Healthcare | 8.95% |
| 4 | Communication Services | 6.76% |
| 5 | Financials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Bank of N.T. Butterfield & Son
NTB
$2.41B
| $5.06M | ﹤0.01% |
162,498
-37,458
| -19% | -$1.1M |
|
1752
CALL
Sony
SONY
$137B
| $5.05M | ﹤0.01% |
+250,000
| New | +$4.35M |
|
1753
PUT
MetLife
MET
$62.4B
| $5.05M | ﹤0.01% |
107,500
-16,600
| -13% | -$719K |
|
1754
PUT
Cardinal Health
CAH
$53.7B
| $5.04M | ﹤0.01% |
94,100
+8,300
| +10% | +$431K |
|
|
VYGG
1755
DELISTED
Vy Global Growth
VYGG
| $5.04M | ﹤0.01% |
+483,375
| New | +$5.04M |
|
1756
Cardlytics
CDLX
$22.2M
| $5.03M | ﹤0.01% |
3,520
-4,642
| -57% | -$4.95M |
|
1757
Diageo
DEO
$49.6B
| $5.02M | ﹤0.01% |
31,625
+6,090
| +24% | +$908K |
|
1758
PUT
Huntington Ingalls Industries
HII
$11B
| $5.01M | ﹤0.01% |
29,400
-10,000
| -25% | -$1.59M |
|
|
SPLK
1759
DELISTED
Splunk Inc
SPLK
| $5.01M | ﹤0.01% |
29,494
+18,267
| +163% | +$3.49M |
|
|
CHUY
1760
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $5.01M | ﹤0.01% |
189,051
-6,466
| -3% | -$153K |
|
1761
Adecoagro
AGRO
$1.4B
| $5.01M | ﹤0.01% |
736,289
+21,089
| +3% | +$117K |
|
|
RSVAU
1762
DELISTED
Rodgers Silicon Valley Acquisition Corp. Unit
RSVAU
| $5.01M | ﹤0.01% |
+375,000
| New | +$4.58M |
|
1763
HUB Group
HUBG
$2.92B
| $5M | ﹤0.01% |
175,612
+45,768
| +35% | +$1.24M |
|
1764
CALL
Bio-Techne
TECH
$11.2B
| $4.99M | ﹤0.01% |
62,800
+36,400
| +138% | +$2.64M |
|
1765
Cirrus Logic
CRUS
$6.76B
| $4.99M | ﹤0.01% |
60,646
-95,109
| -61% | -$7.15M |
|
1766
PUT
Jack in the Box
JACK
$314M
| $4.98M | ﹤0.01% |
53,700
| – | – |
|
|
BCOV
1767
DELISTED
Brightcove, Inc.
BCOV
| $4.98M | ﹤0.01% |
270,558
-120,731
| -31% | -$1.72M |
|
1768
Kroger
KR
$36.7B
| $4.98M | ﹤0.01% |
156,741
-1,173,625
| -88% | -$38M |
|
1769
PUT
Zoetis
ZTS
$32.7B
| $4.96M | ﹤0.01% |
30,000
| – | – |
|
|
MPT
1770
Medical Properties Trust
MPT
$2.84B
| $4.96M | ﹤0.01% |
227,550
-687,396
| -75% | -$13.4M |
|
1771
CALL
Middleby
MIDD
$6.01B
| $4.95M | ﹤0.01% |
38,400
+8,400
| +28% | +$1.01M |
|
1772
Dentsply Sirona
XRAY
$2.84B
| $4.94M | ﹤0.01% |
94,403
-28,096
| -23% | -$1.39M |
|
1773
CALL
Kraft Heinz
KHC
$32.8B
| $4.94M | ﹤0.01% |
142,500
-100,000
| -41% | -$3.25M |
|
1774
CALL
Wolfspeed
WOLF
$1.04B
| $4.93M | ﹤0.01% |
46,600
+36,600
| +366% | +$2.94M |
|
1775
Coherus Oncology
CHRS
$217M
| $4.93M | ﹤0.01% |
283,570
-303,064
| -52% | -$5.4M |
|
Similar funds
D.E. Shaw & Co's Q4 2020 Portfolio in Review
As of Q4 2020, D.E. Shaw & Co held 4,343 positions worth $112B, up 14% from $97.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $10.3B in Q4 2020, closing 477 positions and reducing 1,508 holdings. Its most notable exit was iShares Gold Trust, an estimated $217M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Snowflake worth $147M.
- D.E. Shaw & Co's largest Q4 2020 buy was Snowflake: 523,721 shares worth $147M.
- D.E. Shaw & Co added most to Snap in Q4 2020, an estimated $362M increase.
- D.E. Shaw & Co's biggest Q4 2020 reduction was Tesla, cutting an estimated $559M.
- D.E. Shaw & Co fully exited iShares Gold Trust in Q4 2020, selling an estimated $217M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q4 2020.
- D.E. Shaw & Co opened 563 new positions and closed 477 in Q4 2020.
- D.E. Shaw & Co's portfolio value rose 14% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.